Ethical Issues in Drug Testing, Approval and Pricing: The Clot-Dissolving Drugs

&
Bioethics 12 (1):79-81 (1998)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

ISBN(s)

019508831X

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,783

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Ethical Issues in Drug Testing, Approval and Pricing: the Clot-Dissolving Drugs by Baruch A. Brody.U. Schueklenk - 1998 - Bioethics 12:79-81.
Ethical Issues in Drug Testing, Approval and Pricing: The Clot-Dissolving Drugs.John Lantos - 1997 - Perspectives in Biology and Medicine 40 (3):455.
Ethical Issues in New Drug Prescribing.Lindsay W. Cole, Jennifer C. Kesselheim & Aaron S. Kesselheim - 2012 - Journal of Bioethical Inquiry 9 (1):77-83.
Delaying approval of a critical drug: Safety, efficacy, economics, compassion. [REVIEW]Leo T. Rosenberg - 1994 - Journal of Medical Humanities 15 (4):243-250.
Pharmacogenetics: Ethical issues and policy options.Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody - 2002 - Kennedy Institute of Ethics Journal 12 (1):1-15.
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
The approval of over-the-counter HIV tests: Playing fair when making the rules. [REVIEW]Melissa Whellams - 2008 - Journal of Business Ethics 77 (1):5 - 15.
Ethical considerations in the testing of biopharmaceuticals for adventitious agents.Richard S. Woodward - 1995 - Science and Engineering Ethics 1 (3):273-282.
Judgments of the fairness of using performance enhancing drugs.John Sabini & John Monterosso - 2005 - Ethics and Behavior 15 (1):81 – 94.
Extraordinary Pricing of Orphan Drugs: Is it a Socially Responsible Strategy for the U.S. Pharmaceutical Industry? [REVIEW]Thomas A. Hemphill - 2010 - Journal of Business Ethics 94 (2):225 - 242.
Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries.Edward R. Balotsky - 2009 - Journal of Business Ethics 84 (S1):75 - 88.
Drug testing and productivity.Nicholas J. Caste - 1992 - Journal of Business Ethics 11 (4):301 - 306.
America's Unjust Drug War.Michael Huemer - 2004 - In Bill Masters (ed.), The New Prohibition. Accurate Press.

Analytics

Added to PP
2014-03-22

Downloads
29 (#549,529)

6 months
6 (#514,728)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Baruch Brody
PhD: Princeton University; Last affiliation: Rice University
Udo Schüklenk
Queen's University

Citations of this work

Community Equipoise and the Architecture of Clinical Research.Jason H. T. Karlawish & John Lantos - 1997 - Cambridge Quarterly of Healthcare Ethics 6 (4):385-396.

Add more citations

References found in this work

No references found.

Add more references